SLC2A1 and neoplasm: In addition, lncRNA FTO-IT1 enhances glycolysis through stabilizing FTO and reducing m6A modification on key glycolytic enzymes such as GLUT1 and PKM2, eventually promoting tumor progression (Fig. 2C) [22].